| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| KalVista Pharmaceuticals, Inc. | Senior VP, Development | Restricted Stock Units | 15,480 | $127,390 | $8.23 | 17 May 2022 | Direct |
| KalVista Pharmaceuticals, Inc. | Senior VP, Development | Employee Stock Option (Right to Buy) | 10,320 | 17 May 2022 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| KALV | KalVista Pharmaceuticals, Inc. | 17 May 2022 | 2 | $0 | 4 | Senior VP, Development | 19 May 2022, 16:59 |
| KALV | KalVista Pharmaceuticals, Inc. | 01 Jun 2021 | 3 | -$138,296 | 4 | Senior VP, Development | 03 Jun 2021, 18:28 |
| KALV | KalVista Pharmaceuticals, Inc. | 26 May 2021 | 1 | $0 | 4 | Senior VP, Development | 28 May 2021, 17:29 |